WINT : Insider Transactions for Windtree Therapeutics Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Windtree Therapeutics Inc (WINT)

$0.16 0.00 (0.00%) as of 4:30 Thu 2/23

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

16,920,000

Market Cap:

2.77(M)

Last Volume:

25,688,722

Avg Vol:

24,231,703

52 Week Range:

$0.164 - $0.164

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Windtree Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of therapeutics to address unmet medical needs in acute care markets. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. In addition, Co. cardiovascular drug product candidates include rostafuroxin, for the treatment of hypertension in patients with a specific genetic profile. Co.'s pulmonary product candidate portfolio consists of a KL4 surfactant platform to address a range of serious respiratory conditions in children and adults.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	2,500	24,812
Total Buy Value	$0	$0	$2,250	$15,204
Total People Bought	0	0	1	2
Total Buy Transactions	0	0	1	8
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-03-03	2023-12-01	2023-06-02	2022-06-02

Adjust Filter Settings

Records found: 619

Page 14 of 25

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Miller Thomas F

SVP, Commercial & Corp Dev

• – –

2010-01-03

4

D

$0.63

$696

D/D

(1,105)

6,895

-

Executive VP & CFO

• – –

2010-01-03

4

A

$0.63

$2,087

D/D

3,312

39,688

-

Executive VP & Legal Counsel

• – –

2010-01-03

4

D

$0.63

$2,087

D/D

(3,312)

53,834

-

Executive VP & Legal Counsel

• – –

2009-12-31

5

A

$0.63

$1,875

I/I

2,976

23,389

-

Exec. VP, CFO

• – –

2009-12-31

5

A

$0.63

$2,063

I/I

3,274

24,594

-

Miller Thomas F

SVP, Commercial..& Corp. Dev.

• – –

2009-12-31

5

A

$0.63

$2,063

I/I

3,274

22,029

-

Segal Robert-Md

Sr VP, Chief Medical Officer

• – –

2009-12-31

5

A

$0.63

$2,063

I/I

3,274

24,593

-

Senior VP, Human Resources

• – –

2009-12-31

5

A

$0.63

$2,063

I/I

3,274

20,226

-

Katzer Charles F

SVP, Manufacturing Operations

• – –

2009-12-31

5

A

$0.63

$1,875

I/I

2,976

9,381

-

Executive VP & Legal Counsel

• – –

2009-09-30

5

A

$0.61

$1,876

I/I

3,075

20,413

-

Exec. VP, CFO

• – –

2009-09-30

5

A

$0.61

$2,063

I/I

3,382

21,320

-

Miller Thomas F

SVP, Commercial..& Corp. Dev.

• – –

2009-09-30

5

A

$0.61

$2,063

I/I

3,382

18,755

-

Segal Robert-Md

Sr VP, Chief Medical Officer

• – –

2009-09-30

5

A

$0.61

$2,062

I/I

3,381

21,319

-

Senior VP, Human Resources

• – –

2009-09-30

5

A

$0.61

$2,062

I/I

3,381

16,952

-

Katzer Charles F

SVP, Manufacturing Operations

• – –

2009-09-30

5

A

$0.61

$1,875

I/I

3,074

6,405

-

Executive VP & Legal Counsel

• – –

2009-06-30

5

A

$1.06

$1,875

I/I

1,769

17,338

-

Exec. VP, CFO

• – –

2009-06-30

5

A

$1.06

$2,063

I/I

1,946

17,938

-

Miller Thomas F

SVP, Commercial..& Corp. Dev.

• – –

2009-06-30

5

A

$1.06

$2,062

I/I

1,945

15,373

-

Segal Robert-Md

Sr VP, Chief Medical Officer

• – –

2009-06-30

5

A

$1.06

$2,063

I/I

1,946

17,938

-

Senior VP, Human Resources

• – –

2009-06-30

5

A

$1.06

$2,063

I/I

1,946

13,571

-

Katzer Charles F

SVP, Manufacturing Operations

• – –

2009-06-30

5

A

$1.06

$1,875

I/I

1,769

3,331

-

Capetola Robert J

Former President/CEO

– – –

2009-06-30

5

A

$1.06

$2,062

I/I

1,945

17,938

-

Capetola Robert J

Former President/CEO

– – –

2009-04-08

5

GD

$1.72

$25,800

D/D

15,000

418,479

-

Executive VP & Legal Counsel

• – –

2009-03-31

5

A

$1.20

$1,874

I/I

1,562

15,569

-

Exec. VP, CFO

• – –

2009-03-31

5

A

$1.20

$2,062

I/I

1,718

15,992

-

619 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 14 of 25

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.